The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis
- 9 December 1997
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 153 (1), 50-53
- https://doi.org/10.1016/s0022-510x(97)00179-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The CYP2D6B allele is not overrepresented in a population of German patients with idiopathic Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's diseaseAnnals of Neurology, 1996
- Lack of Relation Between Genetic Polymorphism of Cytochrome P-450IID6 and Sporadic Idiopathic Parkinson's DiseaseClinical Neuropharmacology, 1996
- Association between the oxidative polymorphism and early onset of Parkinson's disease*Clinical Pharmacology & Therapeutics, 1995
- Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's diseaseAmerican Journal of Medical Genetics, 1993
- Mutant debrisoquine hydroxylation genes in Parkinson's diseaseThe Lancet, 1992
- Criteria for diagnosing Parkinson's diseaseAnnals of Neurology, 1992
- Acute Effects of 1‐Methyl‐4‐Phenyl‐1, 2, 3, 6‐Tetrahydropyridine in a Model of Rat Designated a Poor Metabolizer of DebrisoquineJournal of Neurochemistry, 1991
- Debrisoquine oxidation in Parkinson's diseaseActa Neurologica Scandinavica, 1991
- ECOGENETICS OF PARKINSON'S DISEASE: 4-HYDROXYLATION OF DEBRISOQUINEThe Lancet, 1985